Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.2950
-0.0200 (-6.35%)
At close: Mar 20, 2026
Theralase Technologies Employees
Theralase Technologies had 20 employees as of December 31, 2017. The number of employees decreased by 14 or -41.18% compared to the previous year.
Employees
20
Change
-14
Growth
-41.18%
Revenue / Employee
50.05K CAD
Profits / Employee
-217.66K CAD
Market Cap
79.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2017 | 20 | -14 | -41.18% |
| Dec 31, 2015 | 34 | - | - |
Theralase Technologies News
- 12 days ago - Theralase(R) Closes $1.1 M Non-Brokered Private Placement - Newsfile Corp
- 13 days ago - Theralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer - Newsfile Corp
- 4 weeks ago - Correcting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress - Newsfile Corp
- 4 weeks ago - Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress - Newsfile Corp
- 5 weeks ago - Theralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting - Newsfile Corp
- 6 weeks ago - Theralase(R) Provides Update on Bladder Cancer Clinical Study - Newsfile Corp
- 2 months ago - Ferring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Newsfile Corp
- 2 months ago - Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer - Business Wire